
It seems that barely a week goes by at the moment without news of another pharmaceutical company falling foul of …

Many of the biologic drugs on the market today contain sugar molecule components that in some patients could undermine their …
Catalyst specialist Reaxa will lead a consortium, backed by more than £700,000 ($1.1 million) in UK government funding, to develop …
How long has your company been operating? Eden Biodesign is enjoying its tenth anniversary this year. How is your field …
Merck & Co has taken an axe to its network of manufacturing and R&D sites around the world, closing down …
Pfizer has spent $100 million to double the size of a manufacturing facility in Singapore to help it boost its …
Pharmaceutical contract manufacturing is heading for a period of strong growth as drugmakers continue to outsource production to improve efficiency, …
The FDA has published draft guidance aimed at alleviating the burden on pharmaceutical companies of notifying the agency of minor …
Researchers in the US have developed a new synthetic pathway that could make the development of new pharmaceuticals quicker, cleaner …
Pfizer subsidiary Capsugel has won approval from the US Food and Drug Administration for a manufacturing facility based in France …
Pharmaceutical manufacturers will be held more responsible for the activities of their suppliers and outsourcing partners under a new approach …
Researchers at GlaxoSmithKline and two UK universities are working on a technology that could allow active pharmaceutical ingredients to be …
Closure of a manufacturing facility in France operated by Bristol-Myers Squibb could lead to shortages of an important treatment for …
Wastewater from pharmaceutical manufacturing facilities is a major source of drug compounds in the environment, according to a new study …
The European Medicines Agency carried out 175 inspections of manufacturing facilities in 2009, a little lower than its target, according …